Position in NKTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,228,167
+$415,818 QoQ
Shares Held
433,982
+12.7% QoQ
Ownership
0.606%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 136 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 97%
Shared 3%
None 0%
Common Shares in NKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. NKTX ranks #245 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in NKTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,228,167 | 433,982 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $812,349 | 385,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $629,445 | 340,241 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $581,220 | 280,783 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $985,706 | 593,799 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,253,164 | 681,068 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $1,496,133 | 600,857 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,913,012 | 423,233 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,308,496 | 221,404 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $568,692 | 52,608 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $522,508 | 79,168 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $99,381 | 71,498 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $208,776 | 95,332 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $220,007 | 61,974 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $589,517 | 98,417 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $2,433,718 | 184,933 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $2,675,534 | 217,170 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $1,346,105 | 118,287 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,203,077 | 143,523 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $6,498,862 | 233,688 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $778,147 | 24,555 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $953,080 | 28,969 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $6,069,363 | 98,737 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||